Molth

Molecular Technology Innovation for Biomedical Research and Human Health

[Molth @MolthBiotech]

🔎Unlocking the Secrets of ALS with ATAC-seq👏
A new study uses ATAC-seq to reveal epigenomic changes in motor neurons from 380 ALS patients & 80 healthy controls. The results could pave the way for new therapies. Explore the epigenome with our ATAC-Seq Kit & MolthMark platform🧬

[Molth @MolthBiotech]

@NobelPrize Congrat!

[Molth @MolthBiotech]

Happy New Year 2025 from all of us at Molth! 🎇

As we welcome the new year, we celebrate the milestones of 2024 and look forward to advancing science and innovation in 2025. 🌟

Here’s to discoveries and partnerships that shape the future. Let’s make it a year to remember! 🧬

[Molth @MolthBiotech]

Recombinant Antibody Development just got a boost with MolthAb! We harness individual rabbit B cells using our cutting-edge MolthAb technology to deliver antibodies with unmatched specificity and functionality for your research. More details: https://t.co/d8HxAIZ0eM #Antibody

[Molth @MolthBiotech]

🧬 Achieve high-efficiency DNA purification with the Molth Genomic DNA Purification Kit! Featuring novel magnetic nanoparticle technology, it ensures maximum gDNA recovery from diverse sample types. Perfect for your research needs. Request a quote today! #DNAPurification

[Nature Medicine @NatureMedicine]

⚡ Our August issue is out! Featuring studies on #epigenetic screening for #cervicalcancer; #heartfailure; #dialysis; #microbiome; clinical trials of #CARTcelltherapy, #ADCs & #immunotherapy; and more including News, Reviews & Opinion.
Read it here: https://t.co/NrRsGHgLeT

[Molth @MolthBiotech]

🔎Unlocking the Secrets of ALS with ATAC-seq👏
A new study uses ATAC-seq to reveal epigenomic changes in motor neurons from 380 ALS patients & 80 healthy controls. The results could pave the way for new therapies. Explore the epigenome with our ATAC-Seq Kit & MolthMark platform🧬

[Molth @MolthBiotech]

@ScienceMagazine Nice work

[Smart Biology @SmartBiology3D]

"Your videos are well-crafted and detailed! Biology, in particular, is a subject that greatly benefits from visual aids for students to comprehend the essence of the lessons! Thank you @Animator_VMC for sharing. Grateful. Learn more at https://t.co/rZjuFXgP1n

[Stanford Medicine @StanfordMed]

A new Stanford Medicine study reveals two periods of rapid change in our lifespan, occurring around ages 44 and 60.
https://t.co/egFEvdemS9

[Molth @MolthBiotech]

@ScienceMagazine @scisignal Nice work

[Molth @MolthBiotech]

@ScienceMagazine @SciImmunology Nice work!

[Molth @MolthBiotech]

🔬 Introducing the Molth All-in-One NGS Library Prep Kit! Simplify your sequencing workflow with the fastest prep time on the market. Compatible with Illumina, our kit handles various DNA types & quantities, ensuring high-quality libraries every time. Boost your NGS research.

[Molth @MolthBiotech]

@ScienceMagazine @ScienceAdvances Nice work

[Merck @Merck]

Today, we announced the acquisition of a novel investigational bispecific antibody from Curon Biopharma. Learn how this further expands and diversifies our growing pipeline, with potential applications in B-cell malignancies and autoimmune diseases: https://t.co/Tb6yG5BGQc

[Molth @MolthBiotech]

@NIH Nice work

[Molth @MolthBiotech]

@harvardmed Nice work

[Molth @MolthBiotech]

🚀 Discover the power of AI-enhanced biomarker discovery with MolthMark! Our platform combines cutting-edge AI with multiomics analysis to uncover biomarkers linked to diseases, accelerating your research and reducing costs. Read more: https://t.co/qq6QtdfxJW

[Molth @MolthBiotech]

✨ Elevate your antibody development with MolthAb! Our innovative technology optimizes antigen-binding capabilities and enhances specificity, setting new standards in recombinant antibody production. Trust MolthAb to drive your research forward. #Antibodies